GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (FRA:BJX1) » Definitions » E10

BioLife Solutions (FRA:BJX1) E10 : €-0.86 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioLife Solutions E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioLife Solutions's adjusted earnings per share data for the three months ended in Dec. 2024 was €0.248. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.86 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was -30.50% per year. During the past 5 years, the average E10 Growth Rate was -21.20% per year. During the past 10 years, the average E10 Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BioLife Solutions was 23.30% per year. The lowest was -30.50% per year. And the median was 4.60% per year.

As of today (2025-03-25), BioLife Solutions's current stock price is €23.20. BioLife Solutions's E10 for the quarter that ended in Dec. 2024 was €-0.86. BioLife Solutions's Shiller PE Ratio of today is .


BioLife Solutions E10 Historical Data

The historical data trend for BioLife Solutions's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions E10 Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.37 -0.65 -0.79 -0.86

BioLife Solutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 -0.79 -0.85 -0.79 -0.86

Competitive Comparison of BioLife Solutions's E10

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Shiller PE Ratio falls into.



BioLife Solutions E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioLife Solutions's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.248/133.1571*133.1571
=0.248

Current CPI (Dec. 2024) = 133.1571.

BioLife Solutions Quarterly Data

per share eps CPI Adj_EPS
201503 -0.083 99.621 -0.111
201506 -0.071 100.684 -0.094
201509 -0.080 100.392 -0.106
201512 -0.083 99.792 -0.111
201603 -0.090 100.470 -0.119
201606 -0.098 101.688 -0.128
201609 -0.071 101.861 -0.093
201612 -0.246 101.863 -0.322
201703 -0.065 102.862 -0.084
201706 -0.053 103.349 -0.068
201709 -0.025 104.136 -0.032
201712 -0.042 104.011 -0.054
201803 -0.008 105.290 -0.010
201806 0.043 106.317 0.054
201809 0.043 106.507 0.054
201812 0.035 105.998 0.044
201903 -0.912 107.251 -1.132
201906 0.018 108.070 0.022
201909 0.318 108.329 0.391
201912 0.018 108.420 0.022
202003 -0.009 108.902 -0.011
202006 -0.622 108.767 -0.761
202009 -0.034 109.815 -0.041
202012 -0.049 109.897 -0.059
202103 -0.025 111.754 -0.030
202106 0.158 114.631 0.184
202109 0.002 115.734 0.002
202112 -0.327 117.630 -0.370
202203 -0.163 121.301 -0.179
202206 -1.627 125.017 -1.733
202209 -0.242 125.227 -0.257
202212 -1.086 125.222 -1.155
202303 -0.299 127.348 -0.313
202306 -0.212 128.729 -0.219
202309 -0.628 129.860 -0.644
202312 -0.303 129.419 -0.312
202403 -0.202 131.776 -0.204
202406 -0.418 132.554 -0.420
202409 -0.036 133.029 -0.036
202412 0.248 133.157 0.248

Add all the adjusted EPS together and divide 10 will get our e10.


BioLife Solutions  (FRA:BJX1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioLife Solutions E10 Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines